Chaimae Hafidi Alaoui
Overview
Explore the profile of Chaimae Hafidi Alaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Ahanidi H, El Azzouzi M, Addoum B, Tetou M, Hassan I, Al Bouzidi A, et al.
Mol Clin Oncol
. 2025 Feb;
22(4):33.
PMID: 39989605
Signal transducer and activator of transcription (STAT) proteins are cytoplasmic transcription factors known to play key roles in numerous physiological and pathological processes, from pathogen response to cancer modulation. However,...
2.
El Azzouzi M, El Ahanidi H, Hassan I, Tetou M, Ameur A, Bensaid M, et al.
Urol Oncol
. 2024 Aug;
42(12):451.e19-451.e29.
PMID: 39147693
Background: Telomerase activity plays a crucial role in cancer development and progression. Thus, telomerase activation through the interplay of mutations and epigenetic alterations in the telomerase reverse transcriptase (TERT) promoter...
3.
El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, Benbacer L, Tetou M, et al.
Diagnostics (Basel)
. 2023 May;
13(8).
PMID: 37189572
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR1 and VEGFR2) are the most important tissue factors involved in tumor growth and angiogenesis. The aim of this study was to...
4.
AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine
El Ahanidi H, El Azzouzi M, Arrouchi H, Hafidi Alaoui C, Tetou M, Bensaid M, et al.
Pan Afr Med J
. 2022 Mar;
41:59.
PMID: 35317488
Introduction: in cancer cells, activating mutations in PIK3CA and AKT1 genes, major players of PI3K-AKT-mTOR signalling pathway, are widely reported in many cancers and present attractive targets for the identification...
5.
El Ahanidi H, El Azzouzi M, Hafidi Alaoui C, Tetou M, Bensaid M, Chaoui I, et al.
Front Oncol
. 2022 Feb;
11:795242.
PMID: 35223454
Background: Tumor recurrence and progression in non-muscle invasive bladder cancer (NMIBC), therapy failure, and severe side effects in muscle invasive bladder cancer (MIBC) are the major challenges in the clinical...
6.
El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, Benbacer L, Tetou M, et al.
Cancer Genet
. 2021 Dec;
260-261:41-45.
PMID: 34922269
Promoter hypermethylation have been reported to play a key role in bladder cancer development and progression. The aim of this study is to evaluate the methylation status of hTERT, TWIST1,...